Gilead Sciences (GILD) Target Lifted to $101 at Maxim Group

February 5, 2014 9:18 AM

Maxim Group analyst Jason Kolbert reiterated a Buy on Gilead Sciences (NASDAQ: GILD) and raised his price target from $98 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found